logo-loader
CSE:HUGE NASDAQ:HUGE

FSD Pharma Inc

Receive alerts
Market:
CSE
Price
0.99 CAD
Day Change
2.06%
Market Cap:
$38.98 m
52 weeks high
2.83
52 weeks low
0.94

In brief

FSD Pharma Inc, a publicly-traded holding company since 2018, owns subsidiary FSD Pharma BioSciences Inc, a specialty biotech pharmaceutical research and development (R&D) firm focused on developing multiple applications of its lead anti-inflammatory drug FSD-201. The drug is now one of several therapeutics being advanced that could help reduce severe and deadly lung infection in coronavirus (COVID-19) patients. In September 2021, the company closed the acquisition of Canadian psychedelic pharmaceutical company Lucid Psycheceuticals Inc for about C$11.3 million in stock.